Markus Zumbansen
Chief Tech/Sci/R&D Officer at AYOXXA Biosystems GmbH
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Wolfgang Kintzel | M | 57 |
AYOXXA Biosystems GmbH
 AYOXXA Biosystems GmbH BiotechnologyHealth Technology AYOXXA Biosystems GmbH operates as a biotechnology firm. Its lunaris technology is the optimal analysis platform for the pre-clinical and clinical development work. The firm offers In-situ encoded bead array, a multiplexed protein analysis platform that allows users to measure proteins and biomolecular analytes. The company was founded by Dieter Trau and Andreas Schmidt in 2010 and is headquartered in Cologne, Germany. | 9 years |
| Rodney Weldon Turner | M | - |
AYOXXA Biosystems GmbH
AYOXXA Biosystems GmbH BiotechnologyHealth Technology AYOXXA Biosystems GmbH operates as a biotechnology firm. Its lunaris technology is the optimal analysis platform for the pre-clinical and clinical development work. The firm offers In-situ encoded bead array, a multiplexed protein analysis platform that allows users to measure proteins and biomolecular analytes. The company was founded by Dieter Trau and Andreas Schmidt in 2010 and is headquartered in Cologne, Germany. | - |
| Andreas Schmidt | M | - |
AYOXXA Biosystems GmbH
AYOXXA Biosystems GmbH BiotechnologyHealth Technology AYOXXA Biosystems GmbH operates as a biotechnology firm. Its lunaris technology is the optimal analysis platform for the pre-clinical and clinical development work. The firm offers In-situ encoded bead array, a multiplexed protein analysis platform that allows users to measure proteins and biomolecular analytes. The company was founded by Dieter Trau and Andreas Schmidt in 2010 and is headquartered in Cologne, Germany. | 14 years |
| Dieter Trau | M | - |
AYOXXA Biosystems GmbH
AYOXXA Biosystems GmbH BiotechnologyHealth Technology AYOXXA Biosystems GmbH operates as a biotechnology firm. Its lunaris technology is the optimal analysis platform for the pre-clinical and clinical development work. The firm offers In-situ encoded bead array, a multiplexed protein analysis platform that allows users to measure proteins and biomolecular analytes. The company was founded by Dieter Trau and Andreas Schmidt in 2010 and is headquartered in Cologne, Germany. | 14 years |
| Gerald Heinz Möller | M | 80 |
AYOXXA Biosystems GmbH
AYOXXA Biosystems GmbH BiotechnologyHealth Technology AYOXXA Biosystems GmbH operates as a biotechnology firm. Its lunaris technology is the optimal analysis platform for the pre-clinical and clinical development work. The firm offers In-situ encoded bead array, a multiplexed protein analysis platform that allows users to measure proteins and biomolecular analytes. The company was founded by Dieter Trau and Andreas Schmidt in 2010 and is headquartered in Cologne, Germany. | - |
| Markus Hosang | M | - |
AYOXXA Biosystems GmbH
AYOXXA Biosystems GmbH BiotechnologyHealth Technology AYOXXA Biosystems GmbH operates as a biotechnology firm. Its lunaris technology is the optimal analysis platform for the pre-clinical and clinical development work. The firm offers In-situ encoded bead array, a multiplexed protein analysis platform that allows users to measure proteins and biomolecular analytes. The company was founded by Dieter Trau and Andreas Schmidt in 2010 and is headquartered in Cologne, Germany. | - |
| Rainer Christine | M | - |
AYOXXA Biosystems GmbH
AYOXXA Biosystems GmbH BiotechnologyHealth Technology AYOXXA Biosystems GmbH operates as a biotechnology firm. Its lunaris technology is the optimal analysis platform for the pre-clinical and clinical development work. The firm offers In-situ encoded bead array, a multiplexed protein analysis platform that allows users to measure proteins and biomolecular analytes. The company was founded by Dieter Trau and Andreas Schmidt in 2010 and is headquartered in Cologne, Germany. | - |
| Regina Hodits | M | 53 |
AYOXXA Biosystems GmbH
AYOXXA Biosystems GmbH BiotechnologyHealth Technology AYOXXA Biosystems GmbH operates as a biotechnology firm. Its lunaris technology is the optimal analysis platform for the pre-clinical and clinical development work. The firm offers In-situ encoded bead array, a multiplexed protein analysis platform that allows users to measure proteins and biomolecular analytes. The company was founded by Dieter Trau and Andreas Schmidt in 2010 and is headquartered in Cologne, Germany. | - |
| Aristotelis Nastos | M | 56 |
AYOXXA Biosystems GmbH
AYOXXA Biosystems GmbH BiotechnologyHealth Technology AYOXXA Biosystems GmbH operates as a biotechnology firm. Its lunaris technology is the optimal analysis platform for the pre-clinical and clinical development work. The firm offers In-situ encoded bead array, a multiplexed protein analysis platform that allows users to measure proteins and biomolecular analytes. The company was founded by Dieter Trau and Andreas Schmidt in 2010 and is headquartered in Cologne, Germany. | 13 years |
| Karlheinz Schmelig | M | - |
AYOXXA Biosystems GmbH
AYOXXA Biosystems GmbH BiotechnologyHealth Technology AYOXXA Biosystems GmbH operates as a biotechnology firm. Its lunaris technology is the optimal analysis platform for the pre-clinical and clinical development work. The firm offers In-situ encoded bead array, a multiplexed protein analysis platform that allows users to measure proteins and biomolecular analytes. The company was founded by Dieter Trau and Andreas Schmidt in 2010 and is headquartered in Cologne, Germany. | - |
| Barbara Grunewald | M | 72 |
Universität zu Köln
| 25 years |
| Lukas Günther | M | - |
AYOXXA Biosystems GmbH
AYOXXA Biosystems GmbH BiotechnologyHealth Technology AYOXXA Biosystems GmbH operates as a biotechnology firm. Its lunaris technology is the optimal analysis platform for the pre-clinical and clinical development work. The firm offers In-situ encoded bead array, a multiplexed protein analysis platform that allows users to measure proteins and biomolecular analytes. The company was founded by Dieter Trau and Andreas Schmidt in 2010 and is headquartered in Cologne, Germany. | - |
| Reinhard Niessner | M | - |
AYOXXA Biosystems GmbH
AYOXXA Biosystems GmbH BiotechnologyHealth Technology AYOXXA Biosystems GmbH operates as a biotechnology firm. Its lunaris technology is the optimal analysis platform for the pre-clinical and clinical development work. The firm offers In-situ encoded bead array, a multiplexed protein analysis platform that allows users to measure proteins and biomolecular analytes. The company was founded by Dieter Trau and Andreas Schmidt in 2010 and is headquartered in Cologne, Germany. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Xin Liu | F | - |
Universität zu Köln
| 7 years |
| Christiane Hölz | M | 52 |
Universität zu Köln
| 7 years |
| Christoph Heil | M | 59 |
Universität zu Köln
| 4 years |
| Stefan Hettwer | M | - |
Universität zu Köln
| 3 years |
| Anne Umbach | M | - |
Universität zu Köln
| 4 years |
| Anne Ossenbühl | F | - |
Universität zu Köln
| 4 years |
| Mustafa Eser | M | - |
Universität zu Köln
| 2 years |
| Gunnar Stork | M | - |
Universität zu Köln
| 4 years |
| Ingo Heinen | M | - |
Universität zu Köln
| 4 years |
| Axel Tismer | M | - |
Universität zu Köln
| 4 years |
| Daniel Thelen | M | - |
Universität zu Köln
| 5 years |
| Pascal Finette | M | - |
Universität zu Köln
| 5 years |
| Fabian John | M | 44 |
Universität zu Köln
| 7 years |
| Stefan Simon | M | 55 |
Universität zu Köln
| 3 years |
| Klemens Skibicki | M | - |
Universität zu Köln
| 4 years |
| Thomas Ristow | M | 56 |
Universität zu Köln
| 4 years |
| Oliver Frey | M | - |
Universität zu Köln
| 4 years |
| Axel Weber | M | 67 |
Universität zu Köln
| 3 years |
| Markus Schulz | M | - |
Universität zu Köln
| 4 years |
| Marcus Dimpfel | M | 50 |
Universität zu Köln
| 6 years |
| Urs Schoop | M | - |
Universität zu Köln
| 3 years |
| Tom Schröder | M | 50 |
Universität zu Köln
| 4 years |
| Wolfgang Wienand | M | 52 |
Universität zu Köln
| 3 years |
| Shin-Wan Kim | M | 56 |
Universität zu Köln
| 11 years |
| Jochen Ott | M | 50 |
Universität zu Köln
| 5 years |
| Peter Niggemann | M | 59 |
Universität zu Köln
| 3 years |
| Mark Peters | M | - |
Universität zu Köln
| 4 years |
| Thomas J. S. Schubert | M | 54 |
Universität zu Köln
| 3 years |
| Denise Breuer | F | - |
Universität zu Köln
| 4 years |
| Laura Lembke | F | - |
Universität zu Köln
| 4 years |
| David Kuczek | M | - |
Universität zu Köln
| 8 years |
| Uwe Winzen | M | - |
Universität zu Köln
| 3 years |
| Jan Schroeder-Hohenwarth | M | 56 |
Universität zu Köln
| 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Germany | 46 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Markus Zumbansen
- Personal Network
